Jump to Main Content

Advocacy

Policy News

Submit
Reset

2021 Year End Research and Public Health Funding Advocacy Highlights

Dec 16
2021

During 2021, ASH continued to be highly visible in our advocacy for federal support of biomedical research and public health funding, including funding for the National Institutes of Health (NIH), the Centers for Disease Control and Prevention (CDC),...

Read more

2021 ASH Advocacy Efforts to Ensure Patient Access to Care

Dec 16
2021

COVID-19 The COVID-19 crisis continues to play a significant role in ASH’s advocacy and practice-related efforts.  Below is a list of ASH’s key advocacy and practice-related efforts related to COVID-19. In early March, ASH...

Read more

2021 ASH Advocacy Efforts Related to Sickle Cell Disease and Sickle Cell Trait

Dec 16
2021

In 2021, ASH continued to work with federal agencies, leaders at the United States Department of Health and Human Services (HHS) and the U.S. Congress to help enhance and expand government activities in sickle cell disease (SCD) research, training, a...

Read more

2021 Year End Physician Payment and Coverage Advocacy Highlights

Dec 16
2021

Medicare Inpatient Hospital Rule ASH offered comments in June on the fiscal year 2022 proposed rule for the Centers for Medicare and Medicaid Services (CMS) Inpatient Prospective Payment System (IPPS). The rule determines payment levels and related...

Read more

ASH Summary on the Surprise Billing Interim Final Rule

Jul 22
2021

On July 1, 2021, HHS issued an interim final rule with comment period (IFC) to begin the implementation of the No Surprises Act (NSA) which is the law banning “surprise billing” that was enacted by Congress in December 2020.  NSA pro...

Read more

ASH Drug Pricing Update

May 12
2021

Drug Pricing Debate Heats Up in Congress During the second week in May, two key House Committees held hearings to consider drug pricing legislation. The hearings before the House Energy and Commerce Committee and a subcommittee of the Education and...

Read more

2020 ASH Advocacy Efforts to Ensure Patient Access to Care

Dec 10
2020

COVID-19 The COVID-19 crisis dominated much of 2020 and issues surrounding the public health emergency were a main focus of ASH’s advocacy and practice-related efforts. Below is a list of ASH’s key advocacy and practice-related efforts r...

Read more

2020 ASH Advocacy Efforts Related to Sickle Cell Disease

Dec 10
2020

In 2020, ASH continued to work with federal agencies, leaders at the United States Department of Health and Human Services (HHS) and the U.S. Congress to help enhance and expand government activities in sickle cell disease (SCD) research, training, a...

Read more

2020 Year-End Physician Payment and Coverage Advocacy Highlights

Dec 10
2020

Medicare Inpatient Hospital Rule ASH offered comments on the 2020 proposed rule for the Centers for Medicare and Medicaid Services (CMS) Inpatient Prospective Payment System (IPPS). The rule determines payment levels and related provisions for Medica...

Read more

2020 Year-End Research and Public Health Funding Advocacy Highlights

Dec 10
2020

During 2020, ASH continued to be highly visible in our advocacy for federal support of biomedical research and public health funding, including funding for the National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CD...

Read more